Production of Migration Inhibitory Factor in Response to Bacterial and Fungal Antigens in Patients with Untreated Graves' Disease

Overview

Journal Can Med Assoc J

Specialty General Medicine

Date 1980 Jun 7

PMID 6446374

Authors

J R Wall

E A Ryan

Affiliations

Soon will be listed here.

Abstract

Tests for the production of migration inhibitory factor by peripheral blood leukocytes in response to ubiquitous bacterial and fungal antigens were carried out in patients with untreated Graves' disease and in healthy control subjects. Dose-response studies, tests for the production of this factor after 72 hours' stimulation with phytohemagglutinin as a test for reserve, and tests before and after 24 hours' preculture to deplete suppressor cells were also performed in some patients. The antigens used were Candida, Trichophyton-Oidiomyces-Epidermophyton, mumps live attenuated virus and purified protein derivative of tuberculin. The production of migration inhibitory factor was measured by the agarose microdroplet method.The production of migration inhibitory factor in response to all the antigens except mumps virus was slightly greater in the patients than in the control subjects, although the differences were not significant. The dose-response characteristics and the production of migration inhibitory factor after stimulation with phytohemagglutinin were similar in the two groups. The production of migration inhibitory factor in response to suboptimal concentrations of Candida, Trichophyton-Oidiomyces-Epidermophyton and mumps virus was not enhanced in either group after 24 hours' preculture apart from a slight increase in response to mumps virus in the patients.These results fail to support the suggestion that patients with Graves' disease have a deficiency of suppressor cells.

References

HOWIE J, HELYER B . The immunology and pathology of NZB mice. Adv Immunol. 1968; 9:215-66. DOI: 10.1016/s0065-2776(08)60444-7. View

DeGroot L, Jaksina S . Observations on the role of circulating lymphocytes in thyroid auto-immunity. J Clin Endocrinol Metab. 1969; 29(2):207-12. DOI: 10.1210/jcem-29-2-207. View

Hong R, Gatti R, Rathbun J, GOOD R . Thymic hypoplasia and thyroid dysfunction. N Engl J Med. 1970; 282(9):470-4. DOI: 10.1056/NEJM197002262820903. View

Talal N . Immunologic and viral factors in the pathogenesis of systemic lupus erythematosus. Arthritis Rheum. 1970; 13(6):887-94. DOI: 10.1002/art.1780130620. View

Allison A, DENMAN A, Barnes R . Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet. 1971; 2(7716):135-40. DOI: 10.1016/s0140-6736(71)92306-3. View

Talal N, Steinberg A, Jacobs M, Chused T, Gazdar A . Immune cell cooperation, viruses, and antibodies to nucleic acids in New Zealand mice. J Exp Med. 1971; 134(3 Pt 2):52s-64s. View

Mashieu P, WINAND R . Demonstration of delayed hypersensitivity to retrobulbar and thyroid tissues in human exophthalmos. J Clin Endocrinol Metab. 1972; 34(6):1090-2. DOI: 10.1210/jcem-34-6-1090. View

Brody J, Greenberg S . Lymphocyte dysfunction in thyrotoxicosis. J Clin Endocrinol Metab. 1972; 35(4):574-9. DOI: 10.1210/jcem-35-4-574. View

Volpe R, Edmonds M, Lamki L, Clarke P, Row V . The pathogenesis of Graves' disease. A disorder of delayed hypersensitivity?. Mayo Clin Proc. 1972; 47(11):824-34. View

10.

Lamki L, Row V, Volpe R . Cell-mediated immunity in Graves' disease and in Hashimoto's thyroiditis as shown by the demonstration of migration inhibition factor (MIF). J Clin Endocrinol Metab. 1973; 36(2):358-64. DOI: 10.1210/jcem-36-2-358. View

11.

Harrington Jr J, Stastny P . Macrophage migration from an agarose droplet: development of a micromethod for assay of delayed hypersensitivity. J Immunol. 1973; 110(3):752-9. View

12.

Munro R, Lamki L, Row V, Volpe R . Cell-mediated immunity in the exophthalmos of Graves' disease as demonstrated by the migration inhibition factor (MIF) test. J Clin Endocrinol Metab. 1973; 37(2):286-92. DOI: 10.1210/jcem-37-2-286. View

13.

Wara D, Reiter E, Ammann A, Kaplan S . Letter: T-cell rosettes in thyrotoxic Graves's disease. N Engl J Med. 1973; 289(21):1145-6. DOI: 10.1056/NEJM197311222892115. View

14.

Robinson R, Guttler R, Rea T, Nicoloff J . Delayed hypersensitivity in Graves' disease. J Clin Endocrinol Metab. 1974; 38(2):322-4. DOI: 10.1210/jcem-38-2-322. View

15.

Talal N, Steinberg A . The pathogenesis of autoimmunity in New Zealand black mice. Curr Top Microbiol Immunol. 1974; 64(0):79-103. DOI: 10.1007/978-3-642-65848-8_3. View

16.

GOOD R, Yunis E . Association of autoimmunity, immunodeficiency and aging in man, rabbits, and mice. Fed Proc. 1974; 33(9):2040-50. View

17.

Harrington Jr J . Macrophage migration from an agarose droplet: a micromethod for assay of delayed hypersensitivity in the mouse. Cell Immunol. 1974; 12(3):476-80. DOI: 10.1016/0008-8749(74)90103-8. View

18.

Schaller J . Immunodeficiency and autoimmunity. Birth Defects Orig Artic Ser. 1975; 11(1):173-84. View

19.

Mulaisho C, Abdou N, UTIGER R . Lack of T-cell immune abnormalities in peripheral blood lymphocytes in patients with Graves' disease or hypothyroidism. J Clin Endocrinol Metab. 1975; 41(2):266-70. DOI: 10.1210/jcem-41-2-266. View

20.

Pierce C, Peavy D, Tadakuma T . Suppressor T cells as regulators of lymphocyte functions. Ann N Y Acad Sci. 1975; 256:365-74. DOI: 10.1111/j.1749-6632.1975.tb36063.x. View